These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3875310)

  • 41. Antimicrobial susceptibility of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis and/or epididymitis.
    Deguchi T; Ito S; Hatazaki K; Horie K; Yasuda M; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Hanaoka N; Shimuta K; Ohnishi M; Muratani T; Nakano M
    J Infect Chemother; 2017 Nov; 23(11):804-807. PubMed ID: 28619239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
    Odio CM; Kusmiesz H; Shelton S; Nelson JD
    Pediatrics; 1985 May; 75(5):819-26. PubMed ID: 4039433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project.
    Soriano F; Granizo JJ; Coronel P; Gimeno M; Ródenas E; Gracia M; García C; Fernández-Roblas R; Esteban J; Gadea I
    Int J Antimicrob Agents; 2004 Mar; 23(3):296-9. PubMed ID: 15164972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
    Doern GV; Chapin KC
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of respiratory tract infections in children: a study of a combination of amoxycillin and clavulanic acid.
    Fiocchi A; Zuccotti G; Bellù R; Marangione P; Riva E; Giovannini M
    J Int Med Res; 1990; 18(4):326-33. PubMed ID: 2227080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
    Berry V; Hoover J; Singley C; Woodnutt G
    Antimicrob Agents Chemother; 2005 Mar; 49(3):908-15. PubMed ID: 15728883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions.
    Kaiser L; Lew D; Hirschel B; Auckenthaler R; Morabia A; Heald A; Benedict P; Terrier F; Wunderli W; Matter L; Germann D; Voegeli J; Stalder H
    Lancet; 1996 Jun; 347(9014):1507-10. PubMed ID: 8684101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections.
    Bantar C; Nicola F; Fernandez Canigia L; Arenoso HJ; Soutric J; Montoto M; Blanco M; Smayevsky J; Jasovich A
    J Chemother; 2000 Jun; 12(3):223-7. PubMed ID: 10877517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Case of pneumonia caused by beta-lactamase-producing and amoxicillin/clavulanate resistant strains of H. influenzae].
    Yano R; Takayanagi N; Kagiyama N; Harasawa K; Matusita F; Yoneda K; Miyahara Y; Yamaguchi S; Tokunaga D; Saito H; Kurashima K; Ubukata M; Yanagisawa T; Sugita Y
    Nihon Kokyuki Gakkai Zasshi; 2008 Sep; 46(9):753-8. PubMed ID: 18939421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
    Jacobs MR; Bajaksouzian S
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):105-12. PubMed ID: 9294699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada.
    Jansen WT; Verel A; Beitsma M; Verhoef J; Milatovic D
    Curr Med Res Opin; 2008 Oct; 24(10):2853-61. PubMed ID: 18759995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections.
    Brambilla C; Kastanakis S; Knight S; Cunningham K
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):118-24. PubMed ID: 1396725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical comparison of cefuroxime axetil suspension and amoxicillin/clavulanate suspension in the treatment of pediatric patients with acute otitis media with effusion.
    Gooch WM; Blair E; Puopolo A; Paster Z; Schwartz RH; Miller HC; Smyre HL; Giguere GC; Collins JJ
    Clin Ther; 1995; 17(5):838-51. PubMed ID: 8595636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of Haemophilus influenzae with resistant genes isolated from young children with acute lower respiratory tract infections in Nha Trang, Vietnam.
    Gotoh K; Qin L; Watanabe K; Anh DD; Huong Ple T; Anh NT; Cat ND; Ha LL; Ai le TT; Tien NM; Minh TT; Oishi K; Watanabe H
    J Infect Chemother; 2008 Oct; 14(5):349-53. PubMed ID: 18936887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison of amoxicillin and amoxiclav in the therapy of respiratory infections].
    Music E; Kumelj M; Prlja D; Paulin A; Potokar T
    Plucne Bolesti; 1989; 41(3-4):187-92. PubMed ID: 2636405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. beta-Lactamase inhibitors.
    Conner CS
    Drug Intell Clin Pharm; 1985 Jun; 19(6):475-6. PubMed ID: 2988903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients].
    Sudo F; Ishiwada N; Hoshino T; Fukasawa C; Inami Y; Hishiki H; Takeda N; Kurosaki T; Kohno Y
    Kansenshogaku Zasshi; 2005 Sep; 79(9):637-43. PubMed ID: 16248372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.